BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 38652475)

  • 1. [Trends, challenges, and reflections on early-onset gastric cancer].
    Wang XF; Sun YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):425-429. PubMed ID: 38778679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Testing Utilization: Discrepancies Between Somatic and Germline Results in Patients With Cancer Reviewed at the UW Health Precision Medicine Molecular Tumor Board.
    Horn IP; Zakas AL; Smith-Simmer KJ; Birkeland LE; Sundstrom R; Burkard ME; Weiss JM
    JCO Precis Oncol; 2024 May; 8():e2300466. PubMed ID: 38810171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art.
    Rimini M; Presi S; Pipitone GB; Russo Raucci A; Ratti F; Della Corte A; Pedica F; Vanella G; Tonon G; Burgio V; Vitiello F; Rossari F; Amadeo E; Maria Giulia C; Pecciarini L; Arcidiacono PG; Falcinelli F; Cascinu S; De Cobelli F; Aldrighetti L; Patricelli MG; Carrera P; Casadei-Gardini A
    Expert Rev Gastroenterol Hepatol; 2024; 18(4-5):141-146. PubMed ID: 38584510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.
    Al-Ahmadie HA; Iyer G; Lee BH; Scott SN; Mehra R; Bagrodia A; Jordan EJ; Gao SP; Ramirez R; Cha EK; Desai NB; Zabor EC; Ostrovnaya I; Gopalan A; Chen YB; Fine SW; Tickoo SK; Gandhi A; Hreiki J; Viale A; Arcila ME; Dalbagni G; Rosenberg JE; Bochner BH; Bajorin DF; Berger MF; Reuter VE; Taylor BS; Solit DB
    Nat Genet; 2016 Apr; 48(4):356-8. PubMed ID: 26901067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions.
    Herrera-Pariente C; Bonjoch L; Muñoz J; Fernàndez G; Soares de Lima Y; Mahmood R; Cuatrecasas M; Ocaña T; Lopez-Prades S; Llargués-Sistac G; Domínguez-Rovira X; Llach J; Luzko I; Díaz-Gay M; Lazaro C; Brunet J; Castillo-Manzano C; García-González MA; Lanas A; Carrillo M; Hernández San Gil R; Quintero E; Sala N; Llort G; Aguilera L; Carot L; Diez-Redondo P; Jover R; Ramon Y Cajal T; Cubiella J; Castells A; Balaguer F; Bujanda L; Castellví-Bel S; Moreira L
    Gastric Cancer; 2024 May; ():. PubMed ID: 38796558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.
    Rumpf F; Plym A; Vaselkiv JB; Penney KL; Preston MA; Kibel AS; Mucci LA; Salari K
    J Urol; 2024 Apr; ():101097JU0000000000003927. PubMed ID: 38598641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.
    Corso G; Figueiredo J; La Vecchia C; Veronesi P; Pravettoni G; Macis D; Karam R; Lo Gullo R; Provenzano E; Toesca A; Mazzocco K; Carneiro F; Seruca R; Melo S; Schmitt F; Roviello F; De Scalzi AM; Intra M; Feroce I; De Camilli E; Villardita MG; Trentin C; De Lorenzi F; Bonanni B; Galimberti V
    J Med Genet; 2018 Jul; 55(7):431-441. PubMed ID: 29929997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.
    Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
    JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
    Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
    JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
    Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
    Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer predisposition and germline CTNNA1 variants.
    Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
    Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDH1 germline mutations in families with hereditary lobular breast cancer.
    Girardi A; Magnoni F; Vicini E; Kouloura A; La Vecchia C; Veronesi P; Corso G
    Eur J Cancer Prev; 2022 May; 31(3):274-278. PubMed ID: 33990097
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.